tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT

Bolt Biotherapeutics (BOLT) Stock Investors

192 Followers
Based on 744,483 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BOLT
On average, investors allocate 0.00% of their portfolios to BOLT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 744,483 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BOLT

1.8%
Last 7
Days
5.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BOLT, out of 744,483 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BOLT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
<0.01%
$1.22
Increased
0.01%
$0.74
Based on the activity of 14,099 investors who made their portfolios public
The table shows changes in BOLT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BOLT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.76%
-0.93%
-1.61%
32.86B
Consumer Cyclical
ChargePoint Holdings
4.10%
-1.19%
-2.23%
706.00M
Consumer Cyclical
Coherus Biosciences
2.52%
-1.93%
-5.17%
159.47M
Healthcare
Bristol-Myers Squibb
3.19%
+0.15%
+1.35%
81.21B
Healthcare
GE Aerospace
5.28%
+0.19%
+0.87%
178.42B
Industrials
Applied Materials
4.72%
+0.59%
+5.14%
201.45B
Technology
Raytheon Technologies
4.00%
-0.22%
-1.47%
133.93B
Industrials
Riot Platforms
4.93%
-0.09%
+0.18%
2.76B
Financial
VICI Properties
4.08%
+0.37%
+1.19%
28.95B
Real Estate
Baidu
5.09%
+1.42%
+10.61%
32.45B
Communication Services
Based on the activity of 744,483 active portfolios
Open your Smart Portfolio

BOLT Investor Analysis

BOLT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.3%
of BOLT holders
are under 35
Average Segment Performance
Average P/E Ratio21.72
Beta7.33
Dividend Yield6.26%
BOLT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.3%
of BOLT holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.88
Beta11.99
Dividend Yield6.26%
BOLT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
38.5%
of BOLT holders
are over 55
Average Segment Performance
Average P/E Ratio20.87
Beta3.99
Dividend Yield7.61%
Overview of age group and performance of BOLT stock investors
See who invests in BOLT according to age group and performance.

FAQ

How many retail Investors hold BOLT?
<0.1% of TipRanks' retail investors hold BOLT in their portfolios.
    What is BOLT Investor Sentiment?
    BOLT’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BOLT in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of BOLT in the last 7 days.
        What percentage of retail investors changed their holding of BOLT in the last 30 days?
        ▼ 5.1% of TipRanks' retail investors changed their holding of BOLT in the last 30 days.
          What is the average age of retail investors who hold BOLT?
          The average age of BOLT Holders is between 35–55.
            What other stocks have BOLT investors also bought?
            BOLT Investors also bought DKNG, CHPT, CHRS, BMY, GE, AMAT, RTX, RIOT, VICI, BIDU.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AZNAstraZeneca
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              INSMInsmed
              LGNDLigand Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis